Prioritizing context-specific genetic risk mechanisms in 11 solid cancers
Mapping where cancer genes act in specific cell types could help researchers design more targeted prevention and treatment strategies.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Temporal and demographic trends in infective gastroenteritis-related…
Though gastroenteritis deaths fell after 2005, Native American and elderly populations still face disproportionate risk, guiding where prevention efforts matter most.
Near-term implementable findingNext-generation sequencing reveals genetic heterogeneity in…
Comprehensive genetic testing catches more FMF cases missed by standard screening, enabling earlier colchicine treatment and organ-protection monitoring.
Standard additionAustrian real-world experience with standard of care brexucabtagene…
Real-world data confirms brexu-cel delivers strong responses in treatment-resistant lymphoma, with early signs that blood counts might predict who needs closer toxicity monitoring.
Standard additionTherapy-driven clonal dynamics in chronic lymphocytic leukemia
Understanding how leukemia cells evolve under different drugs helps doctors anticipate resistance and plan personalized therapy sequences.